nCage Therapeutics
Cracow
About nCage Therapeutics
nCase Therapeutics is a developer of advanced artificial technologies aimed at triggering the formation of protein cages. The company's protein cages are specialized synthetic Virus-Like Particles (VLPs), designed to either display biological materials on their surface or facilitate the transport of molecules, such as nucleic acids or proteins, into the interior of cells. This technology enables a high-density, multivalent display of antigens, closely resembling the properties and functionality of viruses.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Funding stage: Seed
- Last round: Seed (Jan 2021)
- Website: ncage.org
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/ncage-therapeutics-2626839 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.